
Trump Administration Executive Order (EO) Tracker
The U.S. Food and Drug Administration (FDA) recently issued a review of work done over the last year in advancing its New Era of Smarter Food Safety (New Era) Blueprint, which was released in July 2020. In a corresponding FDA Voices publication, Janet Woodcock, M.D. (Acting FDA Commissioner) and Frank Yiannas (Deputy Commissioner for Food Policy and Response) describe the progress the FDA has made in the last year across areas including enhanced food traceability, improved predictive analytics, leveraging artificial intelligence at import screening, and utilizing alternative ways of conducting inspections. Additionally, the FDA issued a summary of key New Era initiatives for 2021. The year-one achievements and 2021 plans are discussed in more detail below.
The FDA notes that one if its priorities under the FDA Food Safety Modernization Act (FSMA) and as part of the New Era initiative is end-to-end traceability throughout the food supply chain to help identify contaminated foods sources and speed recalls. The FDA is encouraging food manufacturers of all sizes to develop traceability programs that allow entities to track and trace throughout the supply chain.
The FDA’s traceability accomplishments over the last year include publishing the Proposed Rule on Food Traceability and a proposed list of foods to which the rule’s additional recordkeeping requirements would apply.2 The FDA also held three public meetings on the proposed rule discussing the key data elements and critical tracking elements for enhanced traceability. The FDA anticipates issuing a Final Rule in late 2022, consistent with the timing required under a Consent Decree.
Another key FDA initiative is to use data analysis to strengthen predictive capabilities (and by extension, support food safety). To support this goal, the FDA created 21 Forward, a data analysis tool to help identify where there could be disruptions in food supply continuity due to food worker absences because of the pandemic. 21 Forward uses COVID-19 human transmission forecast data from the Centers for Disease Control and Prevention (CDC) to identify areas where COVID-19 could impact key segments of the food system (among other data in-feeds). The FDA believes 21 Forward can also help states with vaccine distribution to food and agriculture workers.
The FDA has been leveraging artificial intelligence via a pilot study to help predict when imported food will pose a greater risk of violation. The FDA believes it will be able to use this information to allocate import review resources to the highest risk products. The second phase of this pilot was launched in February, and is designed to use machine learning to rapidly analyze data and automatically identify connections and patterns that are difficult to determine using other tools.3
The New Era Blueprint calls for the FDA to explore alternative ways to conduct inspections. Due to COVID-19, the FDA began conducting remote inspections of importers subject to the Foreign Supplier Verification Programs rule, which provides the FDA with authority to request records electronically. The FDA conducted a record number of FSVP inspections (more than 1,600) since March 2020 through this remote approach.
The FDA says that many of its priorities have been executed by industry with “an impressive level of engagement by organizations representing farmers, manufacturers, retailers, and other stakeholders.” The FDA plans to bring on additional new partners like technology companies as it continues to move forward.
In the newly-issued “New Era of Smarter Food Safety Select Activities for 2021,”4 the FDA outlines additional work planned under the previously-identified four Core Elements:5
We will continue to monitor FDA’s progress in implementing the New Era of Smarter Food Safety. Should you have any questions, please do not hesitate to contact us.
Authored by Elizabeth Fawell, Maile Gradison Hermida, and Chris Forgues.